ClinicalTrials.govpublic full text
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
solid tumour, adenocarcinoma of the colorectal, adenocarcinoma of the pancreas, monoclonal antibody (mab), antibody dependent cellular cytotoxicity (adcc), complement-dependent toxicity (cdc), non-fucosylated immunoglobulin g, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880654
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.